Study identifies distinct profiles of nonverbal learning disability, offering fresh insights for diagnosis and care

A Minnesota-based company is recalling two types of organic frozen spinach sold nationwide because they may be contaminated with Listeria, a bacteria that can cause serious or even life-threatening illness.

Adding genomic sequencing to newborn blood screening would detect hundreds of additional childhood conditions, providing much earlier diagnosis and treatment, according to a new study. A baby's genome, which stays with them for life, could also be re-examined if a health issue arises during their lifetime.

More than 200 health centers in eastern Congo are running out of essential medicine due to ongoing fighting and a lack of humanitarian aid, the International Committee of the Red Cross (ICRC) warned.

Societal stigma against autistic people may influence how much effort individuals put into 'prosocial' or charitable behaviors, according to a new study.

Immersive virtual reality experiences can reproduce visual hallucination effects, miming those induced by the use of psychedelic substances.

A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice. Not only did up to 88% of the vaccinated mice remain tumor-free (depending on the cancer), but the vaccine reduced—and in some cases completely prevented—the cancer's spread.

Novo Nordisk said Thursday it was buying US biotech firm Akero Therapeutics, which is developing treatments for a number of metabolic diseases, for $4.7 billion.

Using millions of microscope images magnified up to 130,000 times, researchers from Radboud University Medical Center and Toronto have unraveled the structure of two key proteins in the malaria parasite. With this knowledge, scientists are developing new vaccines that block the transmission of parasites via mosquitoes.

At a memorial service in 2022, veteran Air Force Capt. Monte Watts bumped into a fellow former Minuteman III nuclear missile operator, who told him that she had non-Hodgkin lymphoma.

Stacey Knoll thought the court summons she received was a scam. She didn't remember getting any medical bills from Montrose Regional Health, a nonprofit hospital, after a 2020 emergency room visit.

Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin—a critical hormone that regulates blood sugar in the body. Scientists at Scripps Research have discovered a new kind of cell that helps protect insulin production, paving the way to understanding how researchers could prevent or reverse type 1 diabetes.

Skoltech researchers have investigated the way the composition of small molecules called lipids and metabolites varies in the brain in the first hours and days after death.

Long-term exposure to fine air pollution can impair metabolic health by disrupting the normal function of brown fat in mice. A study co-led by the University of Zurich shows that this occurs through complex changes in gene regulation driven by epigenetic mechanisms. The results demonstrate how environmental pollutants contribute to the development of insulin resistance and metabolic diseases.

Three research hospitals in the Republic of Korea are reporting that restless leg syndrome was associated with an increased risk of Parkinson's disease, with 1.6% of patients with restless leg syndrome developing Parkinson's disease vs. 1.0% in matched controls and a shorter average time to diagnosis at a 15-year horizon.

We all know about the benefits of physical activity—not just to reduce the risks of chronic disease and physical injuries but also to improve mental health and productivity at work. But many people just don't get as much physical activity as they should.

If you've watched the movie KPop Demon Hunters and see the word "golden," what happens?

Firearm-related deaths are rising dramatically among high school youth, according to a new study led by Washington State University researchers.

In an exciting scientific first, researchers at the Allen Institute successfully designed a new gene therapy that reversed symptoms related to SYNGAP1-related disorders (SRD) in mice. These are a class of brain disorders that can lead to severe and debilitating symptoms including intellectual disability, epilepsy, motor problems, and risk-taking behaviors in humans. In most cases, SRDs are caused when someone has only one working copy of the SYNGAP1 gene instead of the normal two.